Cargando…
AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
Autocrine motility factor (AMF), which is also known as phosphoglucose isomerase (PGI), enhances tumor cell growth and motility. In this study, we found that AMF and its receptor were both highly expressed in Endometrial Carcinoma (EC) tissues compared to normal tissues. Levels of AMF were increased...
Autores principales: | Li, Yiran, Jia, Yuanhui, Che, Qi, Zhou, Qian, Wang, Kai, Wan, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694908/ https://www.ncbi.nlm.nih.gov/pubmed/26308071 http://dx.doi.org/10.18632/oncotarget.4708 |
Ejemplares similares
-
Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2020) -
POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction
por: Li, Yiran, et al.
Publicado: (2019) -
ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020) -
Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1
por: Li, Yiran, et al.
Publicado: (2019) -
Absence of ERK5/MAPK7 delays tumorigenesis in Atm(−/−) mice
por: Granados-Jaén, Alba, et al.
Publicado: (2016)